Autoimmune diseases are challenging to diagnose and delays in diagnosis and treatment lead to increased disease burden and additional stress on the patient, while lack of clear diagnostic criteria impedes clinical trials. Affinergy is developing a novel diagnostic assays to unambiguously diagnose, stratify and uncover underlying immune status using a small amount of serum. Our current areas of interest are:
Scleroderma and Lupus
Amyotrophic Lateral Sclerosis
Multiple Sclerosis
Vasculitis
Cardiac Sarcoidosis
